Some cancer-related mutations can result in abnormally hyperactive WWP1 proteins, which aberrantly increase polyubiquitinations of some oncoproteins or tumor suppressors and consequently promote tumorigenesis (Courivaud et al., 2015; Wang et al., 2019; Lee et al., 2020). The gene discussed is WWP1; the disease is cancer.